Inside U.S. Generic Drug Approvals: Risk, Regulation & Policy w/ Jennifer Kao
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
Inside U.S. Generic Drug Approvals: Risk, Regulation & Policy w/ Jennifer Kao
-
Narrado por:
-
De:
Subscribe to UnitedHealthcare's Community & State newsletter.
In this episode, Rob Lott interviews Jennifer Kao of the UCLA Anderson School of Management in front of a live audience about her paper in the October 2025 issue of Health Affairs exploring the impact of risk evaluation and mitigation strategies on generic approvals of US pharmaceutical products.
Order the October 2025 issue of Health Affairs.
Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcast
Subscribe to UnitedHealthcare's Community & State newsletter.
Todavía no hay opiniones